DR. MARK WILLIAM WALBERG M.D. NPI 1306884333

NPI Information

  • NPI: 1306884333
  • Provider Name: DR. MARK WILLIAM WALBERG, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3410 WORTH ST
    DALLAS, TX
    ZIP 75246
  • Phone: (214) 370-1000

Map and Directions

Get Directions

NPI Details

DR. Mark William Walberg, M.D. is a medical oncology internal medicine in Dallas, TX with 42 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Mark William Walberg, M.D. NPI is 1306884333. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STANFORD UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1984

The provider's business location address is:

3410 WORTH ST
DALLAS, TX
ZIP 75246-003
Phone: (214) 370-1000
Fax: (214) 370-1026

The NPI 1306884333 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Unclassified drugs (HCPCS:J3490)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of chest without contrast (HCPCS:71250)

The enumeration date for this NPI number is 6/3/2006 and was last updated on 10/26/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyJ6272TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1116591205MEDICAIDTEXAS
2900003369MEDICARE PINTEXAS
3116591207MEDICAIDTEXAS
48B6391MEDICARE PINTEXAS
58A9594MEDICARE PINTEXAS
68R1578OTHERTEXASBLUE CROSS OF TEXAS
7F78524MEDICARE UPINTEXAS
8116591201MEDICAIDTEXAS
98A5982MEDICARE PINTEXAS
10116591206OTHERTEXASCSHCN
118799M4MEDICARE PINTEXAS
128A9595MEDICARE PINTEXAS
138111N1MEDICARE PINTEXAS
1480799KMEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.